Effect of Sodium-Glucose Co-transporter Protein 2 Inhibitors on Arrhythmia in Heart Failure Patients With or Without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

AIM: Arrhythmic events such as atrial fibrillation (AF) are tightly associated with an increased risk of heart failure (HF). Previous studies have shown inconsistent results regarding the association between sodium-glucose co-transporter 2 inhibitors (SGLT2i) and the risk of arrhythmia. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Ziwei, Zheng, Huizhen, Guo, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157597/
https://www.ncbi.nlm.nih.gov/pubmed/35665272
http://dx.doi.org/10.3389/fcvm.2022.902923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157597/
https://www.ncbi.nlm.nih.gov/pubmed/35665272
http://dx.doi.org/10.3389/fcvm.2022.902923

Ejemplares similares